<DOC>
	<DOCNO>NCT02149433</DOCNO>
	<brief_summary>This double-blind randomized control trial assess efficacy adjuvant corticosteroid clinically diagnose Pneumocystis jiroveci pneumonia infant .</brief_summary>
	<brief_title>Pneumocystis Jerovici Pneumonia Infants Steroids</brief_title>
	<detailed_description>The study aim determine whether early administration adjuvant corticosteroid addition high dose oral Co-trimoxazole reduces mortality amongst infant age 2-6 month vertically acquire HIV clinically diagnose Pneumocystis jiroveci pneumonia . Infants randomize receive either steroid regime oral prednisolone 2 mg/kg 7 day , 1 mg/kg 7 day , 0.5mg/kg 7 day total 21 day placebo .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Consecutive infant HIV clinical feature Pneumocystis jiroveci pneumonia require oxygen ( oxygen saturation air &lt; 90 % ) . Clinical diagnosis Pneumocystis jiroveci pneumonia make one study investigator . All infant must HIV ELISA positive expose , oxygen requirement ( saturation air &lt; 90 % ) severe respiratory distress cough . They may also low grade fever , clear chest diffuse sign auscultation feature suggestive Pneumocystis jiroveci infection chest radiography . Previous know allergy hypersensitivity contraindication corticosteroid cotrimoxazole . Previous treatment suspect Pneumocystis jiroveci pneumonia delay start steroid great 24 hour start high dose cotrimoxazole . Patients expose HIV . Infants know preexist active pulmonary cardiac disease . Patients live within Blantyre district unable attend follow QECH . Infants whose parent guardians refuse consent .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Pneumocystis Jiroveci</keyword>
	<keyword>Steroids</keyword>
	<keyword>Infants</keyword>
</DOC>